Xtant Medical Holdings, Inc. revenue
Xtant Medical Holdings, Inc.'s revenue was $134m in fiscal 2025, up 14.2% on the year before. Since fiscal 2010 ($15.4m) it has grown at a compound 15.5% a year. Over the last twelve months it was $110m.
Revenue history
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15 | 30 | 33 | 33 | 35 | 59 | 90 | 83 | 72 | 65 | 53 | 55 | 58 | 91 | 117 | 134 | 110 |
| Growth on the year before | — | +95.6% | +9.4% | +0.3% | +6.8% | +68.0% | +51.7% | −8.2% | −12.6% | −10.4% | −17.5% | +3.6% | +4.9% | +57.5% | +28.4% | +14.2% | — |
| Gross profit | 12 | 21 | 23 | 19 | 22 | 39 | 62 | 50 | 43 | 43 | 34 | 32 | 32 | 55 | 68 | 84 | 65 |
| Gross margin | 78.2% | 69.8% | 68.7% | 57.1% | 63.1% | 65.9% | 69.2% | 60.6% | 60.2% | 65.7% | 64.5% | 58.8% | 55.4% | 60.8% | 58.2% | 62.9% | 59.4% |
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Products | $115M | ▼ 0.5% |
| Orthobiologics | $72.9M | ▲ 9.7% |
| Spinal Implant | $42.3M | ▼ 14.3% |
| Licenses | $18.7M | ▲ 1146.5% |
| License Revenue | $18.7M | ▲ 1146.5% |
| Bill and Hold Transactions | $400,000 | — |
These categories overlap or exclude eliminations, so shares aren't shown.
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $122M | 91.4% | ▲ 16.0% |
| Outside the US | $11.5M | 8.6% | ▼ 2.3% |
From Xtant Medical Holdings, Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | $110m | -14.3% | 17.3% |
| Sanara Medtech Inc. | $110m | 13.0% | 22.6% |
| Owlet, Inc. | $115m | 28.2% | 29.3% |
| Ceribell, Inc. | $102m | 31.7% | — |
| Outset Medical, Inc. | $118m | -1.3% | -3.1% |
| Anika Therapeutics, Inc. | $121m | 5.3% | 0.3% |
Compare with peers
- Sanara Medtech Inc. revenue
- Owlet, Inc. revenue
- Ceribell, Inc. revenue
- Outset Medical, Inc. revenue
- Anika Therapeutics, Inc. revenue
Head to head: SMTI vs XTNTOWLT vs XTNTCBLL vs XTNT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies